Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Aquestive Therapeutics, Inc. AQST G&A

G&A at other companies

AMP

Amphastar PharmaceuticalsAMPH

$18.03M+12.7%

RegenxbioRGNX

$21.31M+4.7%

Avalo TherapeuticsAVTX

$6.85M+23.6%

AnaptysBio, Inc.ANAB

$26.2M+85.4%

Apogee Therapeutics, Inc.APGE

$21.95M+31.4%

Aurinia PharmaceuticalsAUPH

$22.03M+8.3%

Segments

By product

See full

Other$19.93M+233%

Personnel costs$4.8M-27.1%

By segment

See full

Reportable Segment$9.06M-43.8%

Other financials

Income statement

See full

Revenue$14.4M+65.7%

Gross profit$11.0M+117%

Operating income-$4.2M+78.3%

Net income-$8.1M+64.9%

EPS (diluted)-$0.07+70.8%

Balance sheet

See full

Cash & equivalents$110.7M+61.3%

Total debt$64.4M+7.4%

Total equity-$34.1M+44.1%

Total assets$141.1M+38.0%

Cash flow

See full

Operating cash flow-$14.8M+36.7%

CapEx$52.0K-61.5%

Free cash flow-$14.9M+36.9%

Valuation

See full

Market cap$560.13M+73.5%

Enterprise value$513.76M+63.6%

P/S11.1×+5.2×

Profitability

See full

Gross margin63.5%-4.9pp

Operating margin-111.2%+96.3pp

Net margin-137.1%+80.7pp

FCF margin-88.2%-2.2pp

Returns & leverage

See full

Return on equity145.1%—

Debt / equity-1.9×—

Current ratio4.1×-0.8×

Questions, answered.

What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.